Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05522205 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Regulated Cannabis Access in Basel

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 6 months later Jul 31, 2025 → Jan 31, 2027
See other at-risk trials from Health Department of the Canton of Basel-Stadt

Record History

  1. Primary and study completion pushed from Jul 31, 2025 to Jan 31, 2027v4
  2. Re-verified, no change to tracked fieldsv3
  3. Start date changed from estimate of Sep 15, 2022 to Jan 31, 2023
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 370 to confirmed 374
    • Primary and study completion dates: Mar 31, 2025 to Jul 31, 2025
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The randomised controlled study on regulated cannabis access in pharmacies in Basel aims to investigate the effects of regulated cannabis access on consumption behaviour and mental and physical health in comparison to the illegal market.
Trial Details
NCT Number NCT05522205
Lead Sponsor Health Department of the Canton of Basel-Stadt
Collaborators: University of Basel, University Psychiatric Clinics Basel, Psychiatric Services Aargau AG
Conditions
(from sponsor)		 Cannabis Use Disorder, Mental Health Disorder, Physical Illness
Related terms Mental Disorders
Enrollment 374 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov